Purpose Few studies have reported the association between the radiographic
characteristics and the development of pneumonia in patients with chronic obstructive …

Introduction Inhaled corticosteroids (ICSs) are recommended for patients with frequent
exacerbation of chronic obstructive pulmonary disease (COPD). However, accumulating …

Background The use of inhaled corticosteroid (ICS) in patients with chronic obstructive
pulmonary disease (COPD) decreases the frequency of COPD exacerbations. Recently …

Background Although inhaled corticosteroids (ICS) is reportedly associated with a higher
risk of pneumonia in chronic obstructive pulmonary disease (COPD), the clinical implications …

Background: Inhaled corticosteroid (ICS) is known to be associated with higher risk of
pneumonia compared to long-acting bronchodilators in chronic obstructive pulmonary …

Background The use of inhaled corticosteroids in patients with chronic obstructive
pulmonary disease (COPD) has been associated with an increased risk of pneumonia in …

Background A comprehensive analysis of the effects of inhaled corticosteroids (ICS) on
COPD in a real-world setting is required due to safety concerns regarding ICS in COPD. This …

Background: ICS use are known to increase risk of pneumonia in patients with COPD. There
is little data on risk of ICS use in Singapore COPD cohort. Method: Patients attending the …

ICS are anti-inflammatory agents which have been suggested to benefit people with
worsening symptoms of COPD, by improving lung function, reducing exacerbation of …

INTRODUCTION: The use of inhaled corticosteroids (ICS) in COPD may be associated with
an increased risk of pneumonia. Little is known of this risk in newly diagnosed COPD …